Compound information
- Natural Products
- ZC863928
- Molecular Formula
- C20H31N5O5
- Molecular Weight
- 421.232519092 g/mol
- Structure
-
- IUPAC Name
- (2S)-2-[[(2R)-2-(benzyloxycarbonylamino)-4-methyl-pentanoyl]amino]-5-guanidino-pentanoic acid
- InChI
- InChI=1S/C20H31N5O5/c1-13(2)11-16(25-20(29)30-12-14-7-4-3-5-8-14)17(26)24-15(18(27)28)9-6-10-23-19(21)22/h3-5,7-8,13,15-16H,6,9-12H2,1-2H3,(H,24,26)(H,25,29)(H,27,28)(H4,21,22,23)/t15-,16+/m0/s1
- InChI Key
- KFBDTHSSJMQGMW-JKSUJKDBSA-N
- SMILES
- CC(C)C[C@@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O
- Source
- ZINC000004027453
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 30 | Ring Count | 1 |
Heteroatom Count | 10 | Rotatable Bond Count | 12 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 6 |
Topological Polar Surface Area | 166.63 Å2 | LogP | 1.03 |
LogS | -2.628 | LogD | 0.531 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.0 | Pgp substrate | 0.895 |
HIA | 0.01 | F20 % | 0.981 |
F30 % | 0.002 | Caco-2 | -6.555 |
MDCK | -5.797 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.952 | PPB | 52.917 |
VD | 0.372 | Fu | 0.454 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.001 | CYP1A2 substrate | 0.673 |
CYP2A6 substrate | 0.268 | CYP2B6 substrate | 0.43 |
CYP2C19 inhibitor | 0.085 | CYP2C19 substrate | 0.845 |
CYP2C8 substrate | 0.674 | CYP2C9 inhibitor | 0.161 |
CYP2C9 substrate | 0.999 | CYP2D6 inhibitor | 0.015 |
CYP2D6 substrate | 0.421 | CYP2E1 substrate | 0.249 |
CYP3A4 inhibitor | 0.015 | CYP3A4 substrate | 0.977 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.786 | CL | 5.11 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.669 | Hepatotoxicity | 0.044 |
Mutagenicity | 0.015 | Rat Oral Acute Toxicity | 0.04 |
FDAMDD | 0.105 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.007 | Eye Corrosion | 0.003 |
Eye Irritation | 0.0 | Respiratory Toxicity | 0.069 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | -1.38 | IGC50 | 2.058 |
LC50FM | 3.5 | LC50DM | 4.142 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.324 | NR-AR-LBD | 0.35 |
NR-AhR | 0.003 | NR-Aromatase | 0.025 |
NR-ER | 0.39 | NR-ER-LBD | 0.367 |
NR-PPAR-gamma | 0.497 | SR-ARE | 0.106 |
SR-ATAD5 | 0.323 | SR-HSE | 0.058 |
SR-MMP | 0.009 | SR-p53 | 0.029 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.